发明名称 |
Compositions for delivery of insoluble agents |
摘要 |
Compositions and methods of making the same for in vivo delivery of lixivaptan to a subject in need thereof are described. The composition includes a substantially water-insoluble pharmacologically active agent (e.g., lixivaptan) and a substantially water-insoluble matrix forming material (e.g., a Vitamin E semi-ester), wherein the pharmacologically active agent is dispersed in said matrix forming material, and wherein the composition delivers said substantially water-insoluble pharmacologically active agent upon exposure to physiological medium. |
申请公布号 |
US8877746(B2) |
申请公布日期 |
2014.11.04 |
申请号 |
US201013391440 |
申请日期 |
2010.08.24 |
申请人 |
Cardioklne, Inc |
发明人 |
Chen Hailiang;Chen Andrew Xian;Frech Patricia;Abu-Izza Khawla;Schmidt Christoph |
分类号 |
A61K31/55;A61K31/355;A01N43/62;A01N43/16;A61K47/22;A61K31/5517 |
主分类号 |
A61K31/55 |
代理机构 |
Brinks Gilson & Lione |
代理人 |
Brinks Gilson & Lione |
主权项 |
1. A pharmaceutical composition comprising a single oral dosage form including an oil-free and substantially water-free solid dispersion, the dispersion including a therapeutically effective amount of lixivaptan and 50% or more by weight of a vitamin E semi-ester. |
地址 |
Cary NC US |